CDE: [Dean’s Speaker Series] Lessons Learned as a Dentist, Pharmacologist and Throat Cancer Survivor by Dr. Paul Desjardins

Oct, 2019
12:00 PM-01:00 PM

Time: 12:00 – 1:00 pm | Lunch provided
Registration Fee: Free; Registration is required for CE credit.
CE Credits: 1.0 lecture credits


This presentation will be a personal description of one patient’s year long journey from discovery, selection of providers, diagnosis, treatment, and recovery. Specific suggestions for the role of general dentists, their referral network and how they can support their patients through this journey will be discussed. The role of different analgesics, local anesthetics and simple oral care procedures in mouthcare will also be discussed as will the most common short and long term adverse effects of chemoradiation treatment.

Educational Objectives

  • To highlight initial presenting signs and symptoms of pharyngeal cancer
  • To describe the personal and emotional reactions to a cancer diagnosis
  • To present several options by which general dentists and their staff can help these patients
  • To discuss the importance of routine head and neck examinations by dentists
  • To present pharmacologic and non-pharmacologic options for managing oral pain and mucositis


Paul J. Desjardins, DMD, PhD, is a dentist and clinical pharmacologist with 40 years of leadership experience in universities, the pharmaceutical industry and in the drug and device development industries. He received his BS from the University of Rhode Island, his DMD from Tufts University School of Dental Medicine and his Ph.D. in Pharmacology from Georgetown University. He completed a 2 year hospital-based General Practice Residency at The Genesee Hospital and Eastman Dental Center in Rochester, NY. He is an Adjunct Professor at Rutgers School of Dental Medicine and at Tufts University School of Dental Medicine. He led the development and refinement of the post-bunionectomy, dental impaction and acute low back pain models that have been utilized in over 100 clinical trials in 45 different drug and device development programs and is considered one of the world’s experts in human acute pain model development.

Disclosure: Dr. Desjardins receives consulting fees as a clinical consultant to Bayer Consumer Healthcare and Grunenthal SA.. Dr. Desjardins serves on the Board of Directors for Coverys and receives a stipend.

University of Pennsylvania School of Dental Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

University of Pennsylvania School of Dental Medicine designates this activity for 1.0 continuing education credits.